BiotechTubeBiotechTube
Home/ADC Therapeutics/Victor Sandor, MD
VS

Victor Sandor, MD

Non-Executive Director, Board of Directors

ADC Therapeutics

Therapeutic Areas

OncologyHematologic CancersSolid Tumors

ADC Therapeutics Pipeline

DrugIndicationPhase
ZYNLONTA® (loncastuximab tesirine-lpyl)Relapsed or Refractory Large B-cell Lymphoma (after ≥2 prior therapies)Approved
PSMA-targeting ADC (ADCT-901)Prostate Cancer and other PSMA-expressing Solid TumorsPre-IND

Leadership Team at ADC Therapeutics

KP
Kimberly Pope
Senior Vice President of Human Resources
PG
Peter Graham
Chief Legal Officer
DE
David Ege
Chief Technical Officer
View full ADC Therapeutics profile